Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000222219 | SCV000273460 | likely benign | Hereditary cancer-predisposing syndrome | 2015-01-15 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Color Diagnostics, |
RCV000222219 | SCV000686863 | likely benign | Hereditary cancer-predisposing syndrome | 2017-10-06 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003633488 | SCV004558296 | likely benign | Familial adenomatous polyposis 1 | 2023-06-11 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV003997797 | SCV004839620 | likely benign | Classic or attenuated familial adenomatous polyposis | 2023-08-15 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV003633488 | SCV004930413 | benign | Familial adenomatous polyposis 1 | 2024-03-07 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |